| |
|
|
|
|
|
|
|||
|
Blood, 15 April 2007, Vol. 109, No. 8, pp. 3342-3350. Prepublished online as a Blood First Edition Paper on December 19, 2006; DOI 10.1182/blood-2006-09-046698.
IMMUNOBIOLOGY Notch activity synergizes with B-cellreceptor and CD40 signaling to enhance B-cell activation1 Department of Pathology and Laboratory Medicine, 2 Abramson Family Cancer Research Institute, 3 Department of Hematology/Oncology, and 4 Institute for Medicine & Engineering, University of Pennsylvania School of Medicine, Philadelphia How diverse environmental cues are integrated to regulate B-cell activation and development remains poorly understood. Here we show that Notch activity synergizes with B-cell receptor (BCR) and/or CD40 signaling to enhance several aspects of B-cell activation and function. We find that costimulation of follicular B cells with the Notch ligand Delta-like-1 leads to significant increases in BCR- and CD40-mediated proliferation and enhances production of IgG1+ cells in vitro and in vivo. We further find that coengagement of Notch and the BCR results in increased activation of the MAPK pathway, and MAPK and Notch inhibitors prevent B-cell activation events mediated by coengagement of Notch and the BCR. These data suggest that the BCR and CD40 signaling pathways collaborate with the Notch pathway to optimize B-cell activation.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||||